Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetylcysteine in Acute Liver Failure
NCT00896025Phase 4Terminated
- Sponsor
- UT Southwestern Medical Center
- Start
- Dec 2008
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetylcysteine in acute liver failure (ALF), sponsored by UT Southwestern Medical Center. Started Dec 2008; status: terminated.
02
Drugs
acetylcysteine
03
Conditions
acute liver failure (ALF)
Beyond the preview
Go deeper on NCT00896025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00896025.